spirogermanium has been researched along with Metastase in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YC; Falkson, G; Harper, GR; Khandekar, JD; Kuebler, JP; Tormey, DC | 1 |
| Dexeus, FH; Hossan, B; Logothetis, C; Samuels, ML | 1 |
| Brunet, R; Bui, NB; Chauvergne, J; Hoerni, B; Lagarde, C; Le Guillou, M; Richaud, P | 1 |
| Bodurtha, A; Eisenhauer, E; Iscoe, N; Kerr, I; McCulloch, P; Pritchard, K; Quirt, I | 1 |
4 other study(ies) available for spirogermanium and Metastase
| Article | Year |
|---|---|
Phase II study of spirogermanium in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Germanium; Humans; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Receptors, Estrogen; Spiro Compounds | 1984 |
Phase II study of spirogermanium in metastatic prostate cancer.
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Germanium; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Prostatic Neoplasms; Spiro Compounds | 1986 |
[Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Germanium; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Prostatic Neoplasms; Spiro Compounds | 1986 |
A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Germanium; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Spiro Compounds | 1985 |